CSCs were initially identified in acute myeloid leukemia (AML) as a CD34+ CD38- subpopulation capable of initiating leukemia after engraftment in immunodeficient mice (Lapidot et al., 1994). The gene discussed is CD38; the disease is acute myeloid leukemia.